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Abstract The surface expression in Staphylococcus carnosus of
three different fibronectin binding domains (FNBDs), derived
from fibronectin binding proteins of Streptococcus dysgalactiae
and Staphylococcus aureus, has been investigated. Surface
localization of the chimeric proteins containing the FNBDs was
demonstrated. All three surface-displayed FNBDs were demon-
strated to bind fibronectin in whole-cell enzyme-linked binding
assays. Furthermore, for one of the constructs, intranasal
immunizations with the recombinant bacteria resulted in
improved antibody responses to a model immunogen present
within the chimeric surface proteins. The implications of the
results for the design of live bacterial vaccine delivery systems
are discussed.
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1. Introduction
The display of heterologous proteins on bacterial surfaces
has become an important tool in bioscience, with a variety of
research applications, such as live recombinant bacterial vac-
cines, systems for display and screening of peptide and anti-
body libraries, whole-cell adsorbents, recombinant whole-cell
biocatalysts, and cell-based solid-phase diagnostic reagents
[1,2]. Surface display on Gram-negative bacteria, predomi-
nantly represented by Escherichia coli and Salmonella spp.,
has been achieved by inserting target gene fragments into
genes encoding outer membrane proteins, e.g. the genes en-
coding OmpA [3^5], PhoE [6], and LamB [7], of E. coli. Ge-
netic fusions to proteins of ¢lamentous structures, such as
¢mbriae, £agella and pili proteins, have also resulted in the
successful surface display of heterologous proteins on Gram-
negative bacteria [8,9], and several other systems for surface
display have been described (for reviews see [1,2]). The most
common application of bacterial surface display is the devel-
opment of live bacterial vaccine delivery systems, and for this
purpose, several non-pathogenic Gram-positive bacteria have
recently been investigated, with the major advantage of lack
of invasive properties, and thereby no risk of reversion to
pathogenicity [2,10]. Both commensal bacteria, such as Strep-
tococcus gordonii [10,11], and food-grade bacteria, such as
staphylococcal and lactococcal species [12], are being investi-
gated in this context. Two interesting candidates which are
being investigated for such applications are Staphylococcus
xylosus and Staphylococcus carnosus, which are both used as
starter cultures in meat fermentation applications [13,14]. Of
the two staphylococcal species, it was recently shown that S.
carnosus displayed a higher number of heterologous surface
proteins [15]. Surface display of antigens on S. xylosus [16]
has been achieved using fusions to the gene encoding the
signal sequence and cell surface anchoring parts, of Staphylo-
coccus aureus protein A (SPA). When using S. carnosus as a
host for surface expression, the signal sequence and propep-
tide of the Staphylococcus hyicus lipase gene were used togeth-
er with the SPA cell surface anchoring sequences [17]. Surface-
expressed foreign antigens have been anchored to the S. gor-
donii cell wall using fusions to a fragment of the streptococcal
protein M gene [18], a gene which has also been successfully
expressed in Lactobacillus lactis [19]. Although antibody re-
sponses to surface-displayed antigens have been evoked by
oral immunization of mice [20^22], prolonged persistence of
recombinant bacteria would potentially enhance the immune
responses. To achieve increased persistence of the recombi-
nant live bacterial vectors at the mucosal surfaces, an inter-
esting strategy would be the surface expression of adherence
molecules. We have recently shown that the surface expression
of the cholera toxin B subunit (CTB) from Vibrio cholerae on
staphylococci resulted in recombinant staphylococci with the
capacity to bind the ganglioside GM1 [23], present on all
epithelial cells. This strategy, however, depends on the assem-
bly of functional pentamers of CTB, which is not obviously
achievable when having N- and C-terminal extensions to CTB
[24]. More e⁄cient adhesion to mucosal epithelial cells by the
recombinant bacteria might possibly be achieved by surface
display of a protein domain with the capacity to bind in a
monomeric form to its ligand. Fibronectin, present in extrac-
ellular matrices and on epithelial cells [25], is known to bind
various bacteria, which carry surface proteins with ¢bronectin
binding properties [26]. Hanski and coworkers reported in-
creased capacity of Streptococcus pyogenes to adhere to respi-
ratory epithelial cells by the expression of the ¢bronectin
binding protein F in a non-¢bronectin binding strain [27].
Fibronectin binding domains (FNBDs) have previously been
expressed in a functional form on the surface of E. coli as
fusions to £agellin [28], and as fusions to the outer membrane
protein OmpS on the surface of V. cholerae [29]. It would thus
be of interest to investigate whether S. carnosus, which nor-
mally lacks ¢bronectin binding properties, would become able
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to bind ¢bronectin by heterologous display of FNBDs. Here,
the surface expression of three di¡erent ¢bronectin binding
domains on S. carnosus, using the surface display system pre-
viously described [17], is investigated. The FNBDs included in
the study are: (i) A2, a 43 amino acid domain from Strepto-
coccus dysgalactiae ¢bronectin binding protein A [30], (ii) B3,
a 36 amino acid domain, from S. dysgalactiae ¢bronectin
binding protein B [30], and (iii) D3, a 37 amino acid domain,
from S. aureus ¢bronectin binding protein A [31]. Surface
localization and functionality of the recombinant ¢bronectin
binding surface proteins were analyzed by a variety of assays.
2. Materials and methods
2.1. Bacterial strains and plasmids
E. coli strain RRIDM15 [32] was used as bacterial host during the
plasmid constructions. The S. carnosus strain TM300 [33] was used
for surface expression of heterologous ¢bronectin binding proteins.
The general surface display vector pSPPmABPXM [17] was used for
the construction of the expression vectors encoding the ¢bronectin
binding proteins.
2.2. Preparation and transformation of protoplasts
The preparation and transformation of protoplasts from S. carno-
sus cells were performed as described by Goºtz and co-workers [34,35].
2.3. Assembly of the gene fragments encoding ¢bronectin binding
domains
The oligonucleotides (Table 1) were synthesized by phosphorami-
dite chemistry on an Expedite nucleic acid synthesis instrument (Per-
Septive Biosystems, Framingham, MA, USA), and desalted using
NAP-10 columns (Amersham Pharmacia Biotech, Uppsala, Sweden).
After lyophilization, the oligonucleotides were dissolved in water to a
¢nal concentration of 0.5 nmol/ml. The oligos were annealed pairwise
by heating to 70‡C followed by slow cooling to 37‡C. The oligonu-
cleotide pairs were 5P-phosphorylated according to Maniatis et al. [36]
prior to the assembly of the gene fragments by mixing the phosphoryl-
ated pairs, and slowly cooling the mixture from 37‡C to room tem-
perature. The assembled double-stranded gene fragments were ligated
into BamHI/SalI-digested plasmid pSPPmABPXM, yielding the dif-
ferent expression vectors pScA2, pScB3, and pScD3. The nucleotide
sequences of the introduced gene fragments, encoding the di¡erent
¢bronectin binding domains, were veri¢ed by cycle sequencing on
the plasmids with one-dye labelled terminators [37] (DuPont, Wil-
mington, DE, USA) using the sequencing primer SAPA1 (Table 1).
The Sanger fragments were analyzed on an ALF DNA sequencer
(Amersham Pharmacia Biotech). The expression vectors pScA2,
pScB3, and pScD3 were used for transforming S. carnosus proto-
plasts.
2.4. Monoclonal antibodies
Monoclonal antibody FN-3E2, binding to human cellular ¢bronec-
tin and used in the detection of ¢bronectin binding capacity of surface
displayed FNBDs on S. carnosus, was purchased from Sigma (St.
Louis, MO, USA). An albumin binding protein (ABP)-reacting mouse
monoclonal antibody 13F10 [38] was used in the FACScan assay.
2.5. FACScan analysis of the staphylococcal surface display
This assay was performed essentially as described earlier by Robert
and coworkers [15]. Brie£y, wild-type and recombinant S. carnosus
cells were grown at 37‡C to A580nmW7^8. The bacteria were resus-
pended in 0.1% sodium azide in PBS to a ¢nal concentration of
A580nm = 1. Aliquots of 25 Wl of the stock suspension were added to
each conical well of a 96 well microtiter plate and sedimented by
centrifugation for 10 min at 550Ug at 4‡C. After removing the super-
natant, the bacterial suspension was incubated for 30 min with 100 Wl
of an ABP-reacting mouse monoclonal antibody 13F10 [38] diluted
1:1000 in PBS. The cells were resuspended and subsequently incu-
bated 30 min at 4‡C with 100 Wl of £uorescein isothiocyanate
(FITC)-labelled goat anti-mouse IgG (Silenius Laboratories, Mel-
bourne, Australia) at a dilution of 1:200 in PBS. The cells were
washed twice, resuspended in 1 ml of PBS and analyzed on the basis
of £uorescence intensity on a FACScan £ow cytometer (Becton Dick-
inson, Sunnyvale, CA, USA), using 488 nm as excitation wavelength
at 15 mW for the argon ion laser, with saline as sheath bu¡er. Data
for 5000^10 000 cells were collected in List Mode by a LYSYS II
software (Becton Dickinson). The £uorescent light was collected
through a band pass interference ¢lter, with emission detection be-
tween 515 and 545 nm. The cell suspension £uorescence distribution is
represented by £uorescence histograms and mean £uorescence is given
for each histogram.
2.6. Detection of surface displayed ¢bronectin binding domains
Samples from overnight cultures of recombinant or wild-type S.
carnosus cells were diluted 1:100, grown at 37‡C to A578nmW1, and
harvested. In the following assay, unless otherwise indicated, the in-
cubations were performed for 30 min at room temperature, and the
cells were washed twice in PBST (PBS with 0.05% Tween 20) between
the incubation steps. The cells were resuspended in PBST and incu-
bated with ¢bronectin (Sigma) at a concentration of 13 Wg/ml. After
incubation with the monoclonal anti-¢bronectin antibody FN-3E2
(Sigma), diluted 1:500 in PBST, the cells were incubated with alkaline
phosphatase-conjugated goat anti-mouse IgG antibodies (Dako), di-
luted 1:1000 in PBST. The cells were washed once with PBST and
once with substrate bu¡er (1 M diethanolamine-HCl, pH 9.8, 0.5 mM
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Table 1
Nucleotide sequences of the oligonucleotides used in this study
Name Nucleotide sequence (5P-3P)
SAPA-1 CCGAATTCTCGAGGCTCCTAAAGAAAATAC
A2-1 GATCGGCGGCCGCTGCTAGCAGAAGATTCTAAACCAAGTCAAGAAGATGA
A2-2 CCACCAATAATTACTTCATCTTCTTGACTTGGTTTAGAATCTTCTGCTAGCAGCGGCCGCC
A2-3 AGTAATTATTGGTGGTCAAGGTCAAGTAATTGATTTTACAGAAGATACTCAATCT
A2-4 CACCAGACATACCAGATTGAGTATCTTCTGTAAAATCAATTACTTGACCTTGA
A2-5 GGTATGTCTGGTGATAATAGTCATACAGATGGTACAGTTTTAGAAGAGGATCCTGAG
A2-6 TCGACTCAGGATCCTCTTCTAAAACTGTACCATCTGTATGACTATTAT
B3-1 GATCGGCGGCCGCTGCTAGCAGAAGAAAGTTTACCAACTGAACAAGGTCAAT
B3-2 GTTGTACTACCAGATTGACCTTGTTCAGTTGGTAAACTTTCTTCTGCTAGCAGCGGCCGCC
B3-3 CTGGTAGTACAACTGAAGTAGAAGATAGTAAACCTAAATTATCTATTCATTTT
B3-4 GGCCATTCATTATCAAAATGAATAGATAATTTAGGTTTACTATCTTCTACTTCA
B3-5 GATAATGAATGGCCTAAAGAAGATGAGGATCCTGAG
B3-6 TCGACTCAGGATCCTCATCTTCTTTA
D3-1 GATCGGCGGCCGCTGCTAGCATTTAATAAACATACTGAAATTATTGAAGAAGATACA
D3-2 AATAATTTCAGTATGTTTATTAAATGCTAGCAGCGGCCGCC
D3-3 AATAAAGATAAACCTAGTTATCAATTTGGTGGACATAATAG
D3-4 AAATTGATAACTAGGTTTATCTTTATTTGTATCTTCTTC
D3-5 TGTTGATTTTGAAGAAGATACATTACCAAAAGTATCGGATCCTGAG
D3-6 TCGACTCAGGATCCGATACTTTTGGTAATGTATCTTCTTCAAAATCAACACTATTATGTCCACC
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MgCl2), before they were resuspended in substrate bu¡er to
A578nmW0.4. After the addition of p-nitrophenyl phosphate, the
change in A405nm was measured in an ELISA reader (SLT EAR
340AT; SLT-Labinstruments, Groºdig, Austria).
Surface-displayed ¢bronectin binding domains were also detected
employing a colorimetric assay previously used for detection of sur-
face displayed albumin binding domains, as earlier described in detail
[15,17]. Brie£y, the recombinant bacteria were incubated with biotiny-
lated ¢bronectin (Sigma), biotinylated with D-biotinoyl-O-aminocap-
roic acid N-hydroxysuccinimide ester (Boehringer Mannheim, Mann-
heim, Germany) according to the supplier’s recommendations at a
¢nal concentration of 2 Wg/ml for 30 min at 30‡C. Subsequently,
the bacteria were incubated with streptavidin-alkaline phosphatase,
and ¢bronectin binding was monitored by measuring the change in
A405nm after addition of the substrate p-nitrophenyl phosphate.
2.7. Intranasal immunization of mice
Groups of ¢ve BALB/c mice (5 weeks old) were immunized intra-
nasally on days 0, 10 and 20 with 109 wild-type or recombinant S.
carnosus cells in 40 Wl of PBS (20 Wl per nostril) without any adjuvant.
Serum samples were taken on day 0 (preimmune) and day 30, and
ABP-reactive IgG antibodies were measured in an ELISA, essentially
as previously described [39]. Brie£y, microtiter plates were coated
overnight at 4‡C with 100 Wl of recombinant ABP (1 Wg/ml) and
blocked with 0.5% gelatin in PBS. All sera were diluted 1:100 in
dilution bu¡er (PBS containing 0.1% gelatin and 0.05% Tween 20).
Plates were washed with PBS and incubated with 100 Wl horseradish
peroxidase-conjugated goat anti-mouse IgG (Pierce, Rockford, IL,
USA) (1:5000). The reaction was developed with 50 Wl tetramethyl
benzidine (Kirkegaard and Perry Laboratories Inc., Gaithersburg,
MD, USA). A450nm was monitored using an integrated EIA Manage-
ment System (Labsystems). ELISA titers were expressed as the recip-
rocal of the last dilution with A450nms 0.2.
2.8. Nucleotide sequence accession number
The GenBank accession number for the expression vector
pSPPmABPXM is U15516.
3. Results and discussion
3.1. Background
The non-pathogenic bacterium S. carnosus, which is widely
used in food fermentation applications [14], has been exten-
sively investigated as a delivery system for subunit vaccines
[22]. Immunogens of viral, bacterial, or parasitic origin has
been expressed in a surface-exposed form, and immunizations
have been made using the bacteria as whole-cell immunogens.
Moderate antibody responses to the surface-displayed immu-
nogens have been reported when using mucosal route admin-
istration of the bacteria [22]. The short persistence of the
bacteria, estimated to be approximately 70 h [22], could prob-
ably account for the somewhat low antibody responses. One
strategy to increase the immune responses to the surface-dis-
played immunogens could be the co-display of protein do-
mains which potentially could have the capacity to bind to
molecules present on the mucosal epithelium. It could thus be
of relevance to investigate whether ¢bronectin binding protein
domains could be expressed in a functional form on S. carno-
sus, which is devoid of inherent ¢bronectin binding activity
[33]. For the purpose of surface expression on S. carnosus, we
selected three di¡erent FNBDs: (i) a 43 amino acid domain,
denoted A2, from S. dysgalactiae ¢bronectin binding protein
A [30], (ii) a 36 amino acid domain B3, from S. dysgalactiae
¢bronectin binding protein B [30], and (iii) D3, a 37 amino
acid domain, from S. aureus ¢bronectin binding protein A
[31]. The three FNBDs were chosen since they have previously
been shown to inhibit the binding of ¢bronectin to bacterial
cells [30,31,40].
3.2. Assembly of gene constructs encoding ¢bronectin binding
domains
Gene constructs encoding three di¡erent ¢bronectin binding
domains were assembled from synthetic oligonucleotides, us-
ing a method similar to the solid-phase gene assembly method
described by Staîhl and co-workers [41]. The oligonucleotides
(Table 1), used in the gene assembly, were designed to be
pairwise complementary, except for single-stranded 5P protru-
sions of 4^15 nucleotides. The assembled gene fragments had
5P protrusions of four nucleotides, identical with the cohesive
ends given by restriction with endonucleases BamHI and SalI,
respectively. The gene fragments could therefore successfully
be ligated with the BamHI/SalI-restricted general expression
vector pSPPmABPXM yielding the three expression vectors
pScA2, pScB3, and pScD3 (Fig. 1).
3.3. Expression vectors for surface display of ¢bronectin
binding domains on S. carnosus
Three novel E. coli-staphylococci shuttle vectors were con-
structed, designed for surface display of hybrid ¢bronectin
binding domains on S. carnosus. The constructed shuttle vec-
tors, designated pScA2, pScB3 and pScD3 (Fig. 1), encode the
recombinant receptors PP-A2-ABP-XMP, PP-B3-ABP-XMP,
and PP-D3-ABP-XMP, respectively (Fig. 1), anchored in the
cell wall of S. carnosus. The expression vectors utilize the
promoter, signal sequence, and propeptide sequence (PP)
from a S. hyicus lipase gene construct, optimized for expres-
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Fig. 1. Expression vectors with encoded gene products. Abbrevia-
tions: bla, L-lactamase encoding gene; cat, chloramphenicol acetyl-
transferase encoding gene; f1, origin of replication for phage f1;
OriE, origin of replication from E. coli ; OriS, origin of replication
from S. aureus ; pLip, S. hyicus promoter region designed for S. hyi-
cus lipase production in S. carnosus. The expression vectors, suitable
for surface display in S. carnosus, are shown with their encoded fu-
sion products illustrated as anchored to the cell surface. Note that
the propeptide (PP) from the S. hyicus lipase is not processed in S.
carnosus [33], while it is processed in its homologous host, S. hyicus
[47]. This propeptide has been shown to be essential for secretion of
heterologous gene fusion products from S. carnosus [41,48] when us-
ing the lipase signal peptide for the secretion. MP represents the
processed and covalently anchored form [44,45] of the M sequence
of SpA. A: Surface expression vector pScA2 encoding ¢bronectin
binding domain A2 from S. dysgalactiae FnBA, and the processed
gene fusion product PP-A2-ABP-XMP. B: Expression cassette of the
surface expression vector pScB3 encoding ¢bronectin binding do-
main B3 from S. dysgalactiae FnBB, and the processed gene fusion
product PP-B3-ABP-XMP. C: Expression cassette of the surface ex-
pression vector pScD3 encoding ¢bronectin binding domain D3
from S. aureus ¢bronectin binding protein A, FnBPA, and the proc-
essed gene fusion product PP-D3-ABP-XMP.
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sion in S. carnosus [42]. The vector system contains gene frag-
ments from S. aureus protein A (SPA); comprising X, a
charged repetitive region postulated to interact with the pep-
tidoglycan cell wall [43], and M, a region, common for Gram-
positive cell surface bound receptors, required for cell surface
anchoring [44,45]. The gene encoding an ABP, derived from
streptococcal protein G [17,46], is also present in all expres-
sion vectors. The ABP region is expressed as the part of the
recombinant receptors closest to the cell wall anchoring motifs
[17]. It has been demonstrated to be useful as a reporter pep-
tide in a colorimetric assay to analyze surface accessibility of
the hybrid surface proteins [15,17], and has previously also
been shown to act as a spacer protein to increase surface
accessibility [22].
3.4. Detection of recombinant surface-displayed chimeric
proteins
To investigate if the encoded chimeric surface proteins were
expressed and surface-exposed, wild-type and recombinant S.
carnosus cells were analyzed in a £uorescence-activated cell
sorting (FACScan) assay [15,17]. Since the ABP region was
present in the various chimeric surface proteins, and since the
surface exposure of this region has proven to be indicative of
a successful surface display [15,17,38,39], the presence of the
ABP region was monitored by FACScan analysis using an
ABP-reactive mouse monoclonal antibody 13F10 [38]. The
bacterial cells were probed with the monoclonal antibody,
and thereafter £uorescently stained using a FITC-labelled sec-
ondary antibody, to allow FACS analysis. Positive responses
in the FACScan assay, shown as an increase in £uorescence
intensity (Fig. 2), were obtained for S. carnosus cells trans-
formed with the parental vector pSPPmABPXM, carrying
surface-exposed PP-ABP-XMP fusion proteins, and S. carno-
sus cells transformed with plasmids pScA2, pScB3 and pScD3,
while wild-type S. carnosus cells, as expected, remained neg-
ative in this assay (Fig. 2). The signi¢cant and homogeneous
increase in £uorescence intensity observed for the recombi-
nant staphylococci, as compared to wild-type S. carnosus
(Fig. 2), indicate that close to 100% of the recombinant bac-
teria expose numerous copies of the chimeric surface proteins
[39]. In a previous study, it was demonstrated that S. carnosus
cells transformed with the parental vector pSPPmABPXM
carried approximately 104 surface-exposed chimeric pro-
teins [38]. Since the £uorescence histograms for the
pSPPmABPXM-transformed S. carnosus and the staphylococ-
ci carrying the FNBDs have similar intensity distributions and
mean £uorescence reactivities (Fig. 2), it is likely that these
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Fig. 2. Flow cytometry analysis (FACScan) of wild-type and re-
combinant S. carnosus cells probed with a monoclonal antibody
13F10 [38], reactive with the ABP part of the recombinant recep-
tors, and stained with FITC-labelled secondary antibody. The histo-
grams show non-stained bacterial cells displayed to the left in the
histograms and cells which expose ABP-containing surface proteins
on their surfaces shifted to the right. The type of analyzed bacteria
and mean £uorecense reactivity is given for each histogram. Wild-
type (WT) and recombinant S. carnosus cells ; pSPPmABPXM-trans-
formed (ABP), pScA2-transformed (A2), pScB3-transformed (B3),
pScD3-transformed (D3)
Fig. 3. Functional analysis of ¢bronectin binding domains displayed
by whole cells. Histogram of whole-cell binding capacity of the re-
combinant staphylococci to human cellular ¢bronectin. Intact staph-
ylococcal cells were incubated with ¢bronectin, followed by incuba-
tion with a monoclonal anti-¢bronectin antibody. After incubation
with an alkaline-phosphatase conjugate and the addition of a chro-
mogenic substrate, the ¢bronectin binding capacity of the recombi-
nant staphylococci was monitored by a color shift. Bars indicate the
A405nm response for S. carnosus cells : pSPPmABPXM-transformed
(bar 1), pScA2-transformed (bar 2), pScB3-transformed (bar 3),
pScD3-transformed (bar 4). The background response of the S. car-
nosus wild-type cells is subtracted from the responses of the re-
combinant S. carnosus cells. All samples were run in triplicate.
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recombinant staphylococci also display surface proteins in
numbers of the same order of magnitude.
Recombinant and wild-type S. carnosus cells were further
analyzed in a previously described colorimetric assay [15,17],
for the presence of ABP-containing surface-accessible recep-
tors. Recombinant and wild-type S. carnosus cells were incu-
bated with biotinylated human serum albumin, prior to the
addition of a streptavidin-alkaline phosphatase conjugate, and
the presence of ABP-containing surface-accessible receptors
was analyzed by the addition of chromogenic substrate and
the color shift was monitored. This assay gave very similar
results as the FACScan assay (data not shown). These results
demonstrate that hybrid receptors with serum albumin bind-
ing capacity were accessible on the surfaces of the recombi-
nant S. carnosus cells.
3.5. Functional characterization of the ¢bronectin binding
receptors
The ¢bronectin binding capacity of the surface-displayed
hybrid receptors was characterized in an assay based on the
binding of human ¢bronectin to the recombinant S. carnosus
cells. Fibronectin bound to the cells was detected by an en-
zyme-linked immunoassay (Fig. 3). The staphylococcal cells
were incubated with ¢bronectin, and a monoclonal anti-¢bro-
nectin antibody was allowed to react with the cells. After
incubation with enzyme-labelled goat anti-mouse IgG anti-
bodies, the presence of cell-bound ¢bronectin was detected
with a chromogenic substrate. Signi¢cant binding of ¢bronec-
tin was observed for the recombinant staphylococci harbour-
ing plasmids pScA2, pScB3 and pScD3 (Fig. 3, bars 2, 3, and
4), while only background binding was demonstrated for S.
carnosus cells transformed with the parental vector carrying
the PP-ABP-XMP chimeric protein (Fig. 3, bar 1). Further-
more, wild-type S. carnosus cells showed only background
reactivity in this assay (data not shown).
The recombinant S. carnosus cells expressing hybrid recep-
tors were further investigated in a modi¢ed assay for their
¢bronectin binding capacity. The binding of biotinylated ¢-
bronectin to the cells was analyzed by the addition of strep-
tavidin-conjugated alkaline phosphatase, and subsequently its
substrate, and again, the S. carnosus cells harboring plasmids
pScA2, pScB3, and pScD3 showed signi¢cantly higher binding
to biotinylated ¢bronectin than did the wild-type cells and the
cells harboring the parental plasmid pSPPmABPXM (data
not shown). These results clearly suggest that the recombinant
S. carnosus cells have gained ¢bronectin binding capacity by
the expression of FNBDs as parts of their chimeric surface
receptors.
3.6. Immunization experiments
Since the goal of the study was to improve the antibody
responses to surface-displayed proteins on the staphylococcal
cells, mice were immunized intranasally with the wild-type and
recombinant S. carnosus cells in order to evaluate whether the
¢bronectin binding capacity would in£uence the antibody re-
sponses to the ABP region, seen as a model immunogen in
this assay. Serum IgG responses to ABP were monitored, and
interestingly, S. carnosus cells harboring the pScB3 plasmid
did evoke signi¢cantly higher serum IgG responses to ABP
than did the other constructs (Fig. 4). All preimmune sera
were negative in this assay (data not shown). The reason
why the B3 FNBD-displaying staphylococci induced higher
immune responses to ABP, while the two other constructs
did not, remains to be elucidated.
3.7. Concluding remarks
We have in this study assembled gene fragments encoding
three di¡erent ¢bronectin binding domains, and expressed
these as parts of chimeric surface proteins on the food-grade
Gram-positive bacterium S. carnosus. It was found that the
FNBD-containing surface proteins were successfully exposed
on the surface of the staphylococci, as analyzed by a FACS-
can assay. Furthermore, it could be concluded that the re-
combinant S. carnosus cells, carrying surface-exposed FNBDs,
had obtained ¢bronectin binding capacity. This was demon-
strated using a monoclonal antibody reactive to ¢bronectin.
In addition, recombinant S. carnosus cells, carrying the B3
domain from S. dysgalactiae ¢bronectin binding protein B,
demonstrated improved antibody responses to the ABP re-
gion, present in the chimeric protein, thus suggesting that
this construct might have gained improved properties as a
mucosal route vaccine delivery system. Before stating that
this is a general phenomenon, several questions need to be
further addressed. For example, it would be of interest to
evaluate whether the recombinant staphylococci show im-
proved persistence in the gastrointestinal or in the nasal tract
after oral or intranasal administration. Nevertheless, we have
demonstrated that an adherence molecule, as exempli¢ed by
the bacterial FNBDs, could be expressed in a functional form
on the surface of recombinant staphylococci intended for sub-
unit vaccine delivery, and that the surface display of B3
FNBD demonstrated positive e¡ects on the antibody re-
sponses to a co-displayed model antigen. We believe that
such strategies will be of importance to improve mucosal
route vaccine delivery systems.
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